Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

Doctors explain why headaches are popular among Wegovy and Ozempic patients and how to treat and prevent them, including ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the ...

Zepbound shows fewer side effects than Wegovy in obesity treatment study Research highlights Zepbounds advantages over Wegovy in treating obesity with less nausea.

What are the side effects of taking Zepbound? The researchers noted in the study that the most common side effects in people who took Ozempic and Zepbound were gastrointestinal.

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.

Some consumers are taking smaller than standard doses of GLP-1s—the popular class of weight-loss and diabetes drugs that include Ozempic, Wegovy, and Zepbound—or spacing out doses longer than ...

Part of the controversy surrounding weight loss drugs like Ozempic and Mounjaro involve their side effects.

Side effects were similar, though far more Zepbound patients reported pain or swelling at the site of the shot and slightly more Wegovy patients stopped treatment because of side effects such as ...